Medications That May Deplete VITAMIN E

Vitamin E is an antioxidant that helps protect your cells from damage, and it plays a role in immune function and nerve health. Altretamine belongs to a class of chemotherapy drugs called alkylating agents, and there is some early research suggesting these medications may reduce vitamin E levels in the blood, possibly because they place extra oxidative stress on the body that uses up this vitamin. That said, the evidence here is genuinely thin, and experts simply do not yet know whether this matters clinically for most patients. If you have concerns about your nutrient levels while on chemotherapy, that is a good conversation to bring to your oncologist or pharmacist.

Vitamin E is an antioxidant that helps protect your cells from damage, and some alkylating chemotherapy drugs, the class bendamustine belongs to, have been linked to lower vitamin E levels in the blood, possibly because these powerful drugs place extra oxidative stress on the body and may use up vitamin E faster than usual. That said, the evidence here is listed as insufficient, meaning researchers simply do not yet have enough data to know how often this happens with bendamustine or whether it causes real problems. If you are on bendamustine long-term, it is worth mentioning this topic to your oncologist or pharmacist before considering any supplements.

Vitamin E is an antioxidant that helps protect your cells from damage, and some chemotherapy drugs in the same class as bendamustine have been linked to lower levels of it in the blood, possibly because these drugs place extra oxidative stress on the body that uses vitamin E up more quickly. That said, the evidence for bendamustine specifically is thin, and whether any dip in vitamin E levels actually causes harm is not yet clear. If you are taking bendamustine long-term, it is worth mentioning this to your oncologist or pharmacist, but please do not start a vitamin E supplement on your own without checking first.

Vitamin E is an antioxidant that helps protect your cells from damage, and it plays a role in immune function. Research has found that busulfan and some similar chemotherapy drugs can be associated with lower vitamin E levels in the blood, possibly because these powerful medications affect how the body handles certain nutrients, especially at high doses. That said, the evidence here is limited and the clinical significance is simply not known yet, so this is not something most patients need to worry about on their own. If you have questions about your nutrient levels during chemotherapy, your doctor or pharmacist is the right person to ask.

Vitamin E is an antioxidant your body uses to protect cells from damage, and there is some early research suggesting that alkylating chemotherapy drugs, a group that includes carboplatin, may lower vitamin E levels in the blood, possibly because these powerful drugs place extra demands on the body's antioxidant defenses. That said, the evidence here is genuinely limited, and researchers do not yet know whether this matters clinically for most patients. If you are on carboplatin long-term and are curious about your vitamin E status, it is worth raising the question with your oncologist or pharmacist before considering any supplements.

Vitamin E is an antioxidant your body uses to protect cells from damage, and there is some early research suggesting that alkylating chemotherapy drugs like carmustine may lower blood levels of it, possibly because these powerful drugs affect how the body processes certain nutrients at high doses. That said, the evidence here is genuinely thin, and researchers do not yet know whether this matters much in practice. If you are on carmustine, this is worth mentioning to your oncologist or pharmacist, but there is not enough information right now to recommend any specific action.

Vitamin E is an antioxidant your body uses to protect cells from damage, including cells that are already under stress from chemotherapy. Chlorambucil belongs to a class of drugs called alkylating agents, and there is some early research suggesting that drugs in this group may lower vitamin E levels in the blood, possibly by increasing how fast the body uses it up during treatment. That said, the evidence here is really thin, and right now we simply do not know whether this matters clinically for patients taking chlorambucil. If you have questions about your nutrient levels during treatment, your oncologist or pharmacist is the right person to ask before considering any supplements.

Vitamin E is an antioxidant your cells use to protect themselves from damage. High-dose cisplatin and similar chemotherapy drugs have been associated with lower vitamin E levels in the blood, though exactly why is not fully understood. The evidence here is still thin, and whether this actually affects how you feel or how well treatment goes remains unclear. If you are on cisplatin long-term or at high doses, it is worth mentioning this to your oncologist or pharmacist rather than starting a supplement on your own.

Vitamin E is an antioxidant your cells use to protect themselves from damage, and there is some research suggesting that cyclophosphamide and similar chemotherapy drugs may lower vitamin E levels in the blood, possibly because the treatment increases oxidative stress and the body uses more of it up. That said, the evidence here is rated as insufficient, meaning researchers have noticed a possible connection but it is not yet clear how often this matters or whether it affects how well treatment works or how a patient feels. Some studies even found that levels bounced back between treatment cycles. If you are on cyclophosphamide long-term and curious about this, it is worth bringing up with your oncologist or pharmacist before considering any supplement.

Vitamin E is an antioxidant your body uses to protect cells from damage, including damage that can sometimes come from chemotherapy itself. Dacarbazine belongs to a class of drugs called alkylating agents, and there is some early research suggesting that drugs in this group may lower vitamin E levels in the blood, possibly by interfering with how the body handles it during treatment. That said, the evidence for dacarbazine specifically is thin and the clinical significance is simply not known yet. If you have questions about whether any monitoring or dietary changes make sense for you, that is worth a conversation with your oncology team or pharmacist.

Vitamin E is an antioxidant that helps protect your cells from damage throughout the body. Estramustine is part of a class of drugs called alkylating agents, and some drugs in this family have been linked to lower vitamin E levels in the blood, possibly because they increase the body's demand for it or interfere with how it is used. That said, the evidence for estramustine specifically is quite limited, so we honestly do not know how much this matters in practice. If you have questions about your vitamin levels during treatment, your oncologist or pharmacist is the right person to ask.

Vitamin E is an antioxidant that helps protect your cells from damage and supports your immune system. A handful of studies have looked at whether gemfibrozil, a cholesterol-lowering medication, affects vitamin E levels in the blood, and the results have pointed in different directions. Some found a modest drop, others found no change at all, so right now there simply is not enough consistent evidence to say whether this is something to worry about. Most people taking gemfibrozil do not need to act on this, but if you have concerns, it is worth a quick conversation with your pharmacist or doctor.

Vitamin E is an antioxidant your cells use to protect themselves from damage, and there is some early research suggesting that alkylating chemotherapy drugs like ifosfamide may reduce vitamin E levels in the blood, possibly because these powerful drugs affect how the body handles certain nutrients during treatment. That said, the evidence here is genuinely thin, and researchers do not yet know whether this drop is meaningful in practice. If you are on ifosfamide long-term or at high doses, it is worth mentioning this to your oncologist or pharmacist, who can help decide whether monitoring makes sense for your situation.

Vitamin E is an antioxidant that helps protect your cells from damage, and some research suggests that alkylating chemotherapy drugs like lomustine may lower levels of it in the blood, especially at higher doses. The exact reason is not fully understood, though it may relate to how these medications affect the body's stored nutrients during treatment. That said, the evidence here is genuinely thin, so this is not something to worry about on your own. If you are on lomustine long-term, it is worth mentioning this topic to your oncologist or pharmacist so they can guide you appropriately.

Vitamin E is an antioxidant your cells use to protect themselves from damage, and some chemotherapy drugs in the same broad class as lurbinectedin have been linked to lower vitamin E levels in the blood, possibly because they place extra oxidative stress on the body. That said, the evidence for lurbinectedin specifically is quite limited, and researchers do not yet know whether this is a meaningful concern in practice. Most patients taking lurbinectedin will not need to act on this, but if you are curious about your levels or whether a supplement makes sense for you, it is worth a quick conversation with your oncology pharmacist or doctor.

Vitamin E is an antioxidant that helps protect your cells from damage, and there is some early research suggesting that alkylating chemotherapy drugs like mechlorethamine may lower levels of it in the blood, possibly by increasing how much the body uses up while fighting the stress of treatment. That said, the evidence here is genuinely limited, and for mechlorethamine specifically, no one has firmly established whether this is a real concern or how meaningful it is. If you are on this medication long-term, it is worth mentioning to your doctor or pharmacist, but please do not start a vitamin E supplement on your own without that conversation first.

Vitamin E is an antioxidant your body uses to protect cells from damage, including in nerves and muscles. Melphalan is an alkylating agent, and some drugs in this class have been linked to lower vitamin E levels in the blood, possibly because the chemotherapy process uses up or disrupts the body's antioxidant stores, especially at higher doses. That said, the evidence here is genuinely insufficient, meaning researchers simply do not yet know how much this matters in practice. If you are on melphalan long-term, it is worth mentioning this to your oncologist or pharmacist before considering any supplements.

Vitamin E is an antioxidant your body uses to protect cells from damage, and there is some research suggesting that certain alkylating chemotherapy drugs, a class that includes melphalan flufenamide, may lower serum vitamin E levels, particularly at higher doses. The honest answer right now is that the evidence for this specific drug is too limited to draw firm conclusions, and the clinical significance simply is not known. Most people going through chemotherapy do not need to act on this on their own, but if you have questions about monitoring your vitamin E levels during treatment, that is a great conversation to have with your oncologist or pharmacist.

Vitamin E is an antioxidant that helps protect your cells from damage, and there is some early research suggesting that alkylating chemotherapy drugs like melphalan may lower levels of it in the blood, possibly because high doses of these drugs place extra oxidative stress on the body and use up available vitamin E more quickly. That said, the evidence here is genuinely thin, and no one knows yet whether this matters clinically for most patients. If you are on long-term melphalan therapy, it is worth mentioning this to your oncologist or pharmacist so they can help you weigh whether any monitoring makes sense for your situation.

Vitamin E is an antioxidant that helps protect your cells from damage, and oxaliplatin belongs to a drug class that has been linked to lower vitamin E levels in the blood, possibly because these medications interfere with how the body processes or stores it. That said, the evidence here is truly preliminary, and researchers do not yet know whether this matters clinically for most patients taking oxaliplatin. If you are on long-term chemotherapy with this drug, it is worth mentioning to your oncologist or pharmacist, but please do not start a vitamin E supplement on your own without talking to your care team first.

Procarbazine is an alkylating chemotherapy agent, and there is some early research suggesting that drugs in this class may reduce vitamin E levels in the blood, particularly at higher doses. Vitamin E is an antioxidant your cells use to protect themselves from damage. Researchers have wondered whether lower levels during chemotherapy could affect how well a patient tolerates treatment, but the evidence for procarbazine specifically is far too limited to draw any firm conclusions. If you have questions about your nutrient levels during treatment, your oncologist or pharmacist is the right person to ask.

Vitamin E is an antioxidant that helps protect your cells from damage, and there is some early research suggesting that alkylating chemotherapy drugs like streptozocin could lower its levels in the blood, possibly because these powerful drugs affect how the body manages certain nutrients at high doses. That said, the evidence here is genuinely thin, so no one can say yet whether this is a real concern for most patients or how often it actually happens. If you are on streptozocin and curious about your vitamin E status, it is worth raising with your oncologist or pharmacist before considering any supplement.

Vitamin E is an antioxidant your body uses to protect cells from damage, and there is some early research suggesting that alkylating chemotherapy drugs as a class may lower blood levels of it, possibly by affecting how the body processes or stores it during treatment. Temozolomide belongs to that same drug family, so this connection has been noted, though the evidence specific to temozolomide is thin and the clinical significance is simply not known yet. For most people, this is not something to act on right now, but if you are on long-term treatment, it is worth bringing up with your oncologist or pharmacist.

Vitamin E is an antioxidant your body uses to protect cells from damage, including the cells affected during cancer treatment. Thiotepa, as an alkylating chemotherapy agent, has been reported to reduce vitamin E levels in the blood, possibly because these powerful drugs interfere with how the body handles certain nutrients, especially at higher doses. That said, the evidence here is genuinely thin, and researchers are still unsure whether this dip in vitamin E actually causes problems in practice. If you are on thiotepa and have questions about your nutritional status, it is worth raising with your oncologist or pharmacist before considering any supplement.

Vitamin E is an antioxidant your body uses to protect cells from damage, including during times of physical stress like chemotherapy. Trabectedin belongs to a class of drugs that, at higher doses, has been loosely linked to lower vitamin E levels in the blood, though exactly how this happens is not fully understood. The evidence here is rated insufficient, meaning researchers have noticed a possible connection but cannot yet say whether it matters clinically. If you are on a long course of trabectedin and have concerns, it is worth raising the topic with your oncologist or pharmacist before considering any supplement.